Effect of Neonatal Hyperoxia on Alveolar Development and Infection
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
批准号:
8630581
负责人:
Michael A O'Reilly
金额:
$38.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-10 至 2018-01-31
关键词:
AddressAdolescentAdultAffectAirAlveolarBirthBleomycinBronchopulmonary DysplasiaCartoonsCell ProliferationCellsChildChildhoodChronic lung diseaseDevelopmentDiseaseEnvironmentEnvironmental ExposureEpithelialEpithelial CellsExhibitsFetal LungFetusFibrosisFundingGoalsGrowth and Development functionHealthHospitalsHyperoxiaHypertensionHypoxiaImmuneImmune responseInfantInfectionInflammationInfluenza A virusInjuryLeadLearningLeftLifeLinkLungLung diseasesModelingMusNatural ImmunityNeonatalNewborn InfantOxidation-ReductionOxygenOxygen measurement, partial pressure, arterialPlayPopulationPremature InfantRelative (related person)ReporterRespiratory physiologyRibonucleasesRiskRoleSiblingsStagingStem cellsSuperoxide DismutaseTestingTissuesTransgenic MiceType I Epithelial Receptor CellType II Epithelial Receptor CellViralVirus Diseasesage relatedalveolar epitheliumbasebirth controleosinophilextracellularinjuredinsightlung developmentneonatenovelpostnatalprotein functionpublic health relevancerepairedrespiratoryresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
There is growing evidence that many childhood and adult diseases can be linked to environmental
exposures during critically important stages of growth and development. Being born prematurely is a prime
example of how the environment can adversely affect health later in life. Infants born prematurely have
underdeveloped lungs that are not prepared to breath oxygen. They may also be exposed to excess oxygen
used therapeutically to reduce tissue hypoxia and this can lead to bronchopulmonary dysplasia (BPD), a
chronic lung disease seen in preterm infants needing supplemental oxygen. While many preterm infants
eventually leave the hospital, they often suffer as children and adolescents from a variety of persistent
pulmonary diseases (PPD), including reduced lung function and increased respiratory viral infections. Thus,
there is an urgent need to understand how oxygen exposure at birth permanently disrupts lung development in
preterm infants and how these persistent changes affect health and wellbeing later in life. To address this
need, we developed a novel model by which mice are exposed to hyperoxia as neonates, recovered in room
air, and then challenged with influenza A virus or bleomycin as adults. Analogous to children born
prematurely, adult mice exposed to neonatal hyperoxia exhibit reduced lung function, mild alveolar
simplification associated with reduced numbers of alveolar epithelial type II cells, learning deficits, and age-
related hypertension. When infected with influenza A virus or administered bleomycin, adult mice exposed to
neonatal hyperoxia displayed increased inflammation and fibrotic disease compared to siblings exposed to
room air as neonates. While investigating how early-life oxygen exposure alters alveolar epithelial
development, we discovered the oxygen environment at birth affects the expansion of type II cells. Relative to
what is observed in room air, alveolar epithelial type II cell expansion is higher when mice are birthed into low
(<17%) or high (e60%) oxygen. This implies type II cell proliferation occurs optimally under low oxygen
tensions, such as in the fetus, is reduced when exposed to room air levels at birth, and increases again at high
oxygen tensions. This increased number of type II cells is then excessively pruned when mice are returned to
room air. Because type II cells play an important role in innate immunity and function as progenitor cells
following epithelial injury, their depletion could be responsible for altering how the lung responds to alveolar
epithelial injury. Here, we test the hypothesis that the oxygen environment at birth controls proper
expansion of type II cells, which are necessary to protect the adult lung from alveolar epithelial injury.
Understanding how the transition to the oxygen environment at birth controls proper expansion of alveolar
epithelial type II cells is important because it could lead to new opportunities for identifying and treating
children born prematurely who are at risk for PPD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of early life hyperoxia on mesenchymal stem cell fate: their impact on age related disease
-
批准号:10312537
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2021
-
负责人:Michael A O'Reilly
-
依托单位:
Role of early life hyperoxia on mesenchymal stem cell fate: their impact on age related disease
-
批准号:10475250
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2021
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:9172674
-
项目类别:
-
资助金额:$11.51万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:9000732
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:10001048
-
项目类别:
-
资助金额:$53.66万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:9767838
-
项目类别:
-
资助金额:$53.66万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:7591323
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:10246362
-
项目类别:
-
资助金额:$53.66万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:8197382
-
项目类别:
-
资助金额:$38.12万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:7746428
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:7989991
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Core--Instrumentation Facility
-
批准号:6867266
-
项目类别:
-
资助金额:$17.65万
-
财政年份:2005
-
负责人:Michael A O'Reilly
-
依托单位:
DNA Repair and Replication in Oxidant Lung Injury
-
批准号:6924577
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
Cell survival and death in oxidant lung injury
-
批准号:8661214
-
项目类别:
-
资助金额:$37.85万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
DNA Repair and Replication in Oxidant Lung Injury
-
批准号:6756459
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
DNA Repair and Replication in Oxidant Lung Injury
-
批准号:6508966
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
Cell survival and death in oxidant lung injury
-
批准号:8279197
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
Cell Survival and Death in Oxidant Lung Injury
-
批准号:7266475
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
Cell survival and death in oxidant lung injury
-
批准号:8468006
-
项目类别:
-
资助金额:$36.77万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
Cell Survival and Death in Oxidant Lung Injury
-
批准号:7388820
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
海外基金